Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital Muenster
Procalcitonin is a protein consisting of 116 amino-acids which can rapidly rise under inflammatory conditions and sepsis. More than 20 years ago it has been shown that dipeptidylpeptidase-4 (DPP-4) cleaves procalcitonin from the n-terminus, resulting in a truncated procalcitonin-variant which consists of 114 aminoacids.
Within their workgroup the investigators found that the truncated procalcitonin-variant had deleterious effects on vascular integrity during sepsis in mice: They observed that binding of truncated procalcitonin to the CRLR/RAMP1-receptor on vascular endothelium lead to phosphorylation and destruction of VE-cadherin, an essential part of adherens junctions. Consequently, paracellular leakage of proteins and fluid from blood vessels developed.
It is unknown if these effects also apply to humans. By using an ELISA-assay the investigators want to examine the ratio between native and truncated human procalcitonin during diseases accompanied with hyperprocalcitoninemia and correlate the results with clinical data. Futhermore, they want to examine if the procalcitonin-variants have influence on cytokine levels and surface antigens on immune cells by performing multiplex immunoassays and FACS-analysis.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \>18
Patients with diagnosis...
Sepsis or,
SIRS after cardiothoracic surgery or,
adipositas or,
granulomatosis with polyangiitis/microscopic polyangiitis or,
pre-eclampsia
healthy control subjects
written informed consent
You may not be if
participation in an interventional study trial within the last 3 months